As the BLT site states they are looking at 7 trial sites.
I suggest the more trial sites the better chance of finding suitable candidates in a larger pool.
Question, do they start from scratch, or will the new patients recieve the dosing of the second cohort?
No bad news here. Status
TT-034 has entered a Phase l/lla human clinical trial:
Benitec has two trial sites - Duke Clinical Research Centre where dosing has commenced and University of California San Diego which is recruiting.
An additional five trial sites are being negotiated, with two expected to be operational in early 2015.
BLT Price at posting:
48.5¢ Sentiment: None Disclosure: Held